221 related articles for article (PubMed ID: 24256410)
1. Discovery of 5-substituted pyrrolo[2,3-d]pyrimidine antifolates as dual-acting inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis: implications of inhibiting 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase to ampk activation and antitumor activity.
Mitchell-Ryan S; Wang Y; Raghavan S; Ravindra MP; Hales E; Orr S; Cherian C; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2013 Dec; 56(24):10016-10032. PubMed ID: 24256410
[TBL] [Abstract][Full Text] [Related]
2. Discovery of amide-bridged pyrrolo[2,3-d]pyrimidines as tumor targeted classical antifolates with selective uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.
Xiang W; Dekhne A; Doshi A; O'Connor C; Hou Z; Matherly LH; Gangjee A
Bioorg Med Chem; 2019 Dec; 27(23):115125. PubMed ID: 31679978
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidines as potential nonclassical antifolates targeting both thymidylate and purine nucleotide biosynthesis.
Liu Y; Zhang C; Zhang H; Li M; Yuan J; Zhang Y; Zhou J; Guo H; Zhao L; Du Y; Wang L; Ren L
Eur J Med Chem; 2015 Mar; 93():142-55. PubMed ID: 25668494
[TBL] [Abstract][Full Text] [Related]
4. Novel 5-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase and as potential antitumor agents.
Wang Y; Mitchell-Ryan S; Raghavan S; George C; Orr S; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2015 Feb; 58(3):1479-93. PubMed ID: 25602637
[TBL] [Abstract][Full Text] [Related]
5. Discovery of 6-substituted thieno[2,3-d]pyrimidine analogs as dual inhibitors of glycinamide ribonucleotide formyltransferase and 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase in de novo purine nucleotide biosynthesis in folate receptor expressing human tumors.
Wallace-Povirk A; Tong N; Wong-Roushar J; O'Connor C; Zhou X; Hou Z; Bao X; Garcia GE; Li J; Kim S; Dann CE; Matherly LH; Gangjee A
Bioorg Med Chem; 2021 May; 37():116093. PubMed ID: 33773393
[TBL] [Abstract][Full Text] [Related]
6. Tumor Targeting with Novel 6-Substituted Pyrrolo [2,3-d] Pyrimidine Antifolates with Heteroatom Bridge Substitutions via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of de Novo Purine Nucleotide Biosynthesis.
Golani LK; Wallace-Povirk A; Deis SM; Wong J; Ke J; Gu X; Raghavan S; Wilson MR; Li X; Polin L; de Waal PW; White K; Kushner J; O'Connor C; Hou Z; Xu HE; Melcher K; Dann CE; Matherly LH; Gangjee A
J Med Chem; 2016 Sep; 59(17):7856-76. PubMed ID: 27458733
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeting with novel non-benzoyl 6-substituted straight chain pyrrolo[2,3-d]pyrimidine antifolates via cellular uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis.
Wang Y; Cherian C; Orr S; Mitchell-Ryan S; Hou Z; Raghavan S; Matherly LH; Gangjee A
J Med Chem; 2013 Nov; 56(21):8684-95. PubMed ID: 24111942
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and discovery of high affinity folate receptor-specific glycinamide ribonucleotide formyltransferase inhibitors with antitumor activity.
Deng Y; Wang Y; Cherian C; Hou Z; Buck SA; Matherly LH; Gangjee A
J Med Chem; 2008 Aug; 51(16):5052-63. PubMed ID: 18680275
[TBL] [Abstract][Full Text] [Related]
9. Novel 6-substituted benzoyl and non-benzoyl straight chain pyrrolo[2,3-d]pyrimidines as potential antitumor agents with multitargeted inhibition of TS, GARFTase and AICARFTase.
Xing R; Zhang H; Yuan J; Zhang K; Li L; Guo H; Zhao L; Zhang C; Li S; Gao T; Liu Y; Wang L
Eur J Med Chem; 2017 Oct; 139():531-541. PubMed ID: 28830032
[TBL] [Abstract][Full Text] [Related]
10. 6-Substituted Pyrrolo[2,3-d]pyrimidine Thienoyl Regioisomers as Targeted Antifolates for Folate Receptor α and the Proton-Coupled Folate Transporter in Human Tumors.
Wang L; Wallace A; Raghavan S; Deis SM; Wilson MR; Yang S; Polin L; White K; Kushner J; Orr S; George C; O'Connor C; Hou Z; Mitchell-Ryan S; Dann CE; Matherly LH; Gangjee A
J Med Chem; 2015 Sep; 58(17):6938-59. PubMed ID: 26317331
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activity of a novel series of 6-substituted thieno[2,3-d]pyrimidine antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors over the reduced folate carrier and proton-coupled folate transporter for cellular entry.
Deng Y; Zhou X; Kugel Desmoulin S; Wu J; Cherian C; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2009 May; 52(9):2940-51. PubMed ID: 19371039
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological, and antitumor activity of a highly potent 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitor with proton-coupled folate transporter and folate receptor selectivity over the reduced folate carrier that inhibits β-glycinamide ribonucleotide formyltransferase.
Wang L; Desmoulin SK; Cherian C; Polin L; White K; Kushner J; Fulterer A; Chang MH; Mitchell-Ryan S; Stout M; Romero MF; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2011 Oct; 54(20):7150-64. PubMed ID: 21879757
[TBL] [Abstract][Full Text] [Related]
13. Tumor Targeting with Novel Pyridyl 6-Substituted Pyrrolo[2,3- d]Pyrimidine Antifolates via Cellular Uptake by Folate Receptor α and the Proton-Coupled Folate Transporter and Inhibition of De Novo Purine Nucleotide Biosynthesis.
Ravindra M; Wallace-Povirk A; Karim MA; Wilson MR; O'Connor C; White K; Kushner J; Polin L; George C; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2018 Mar; 61(5):2027-2040. PubMed ID: 29425443
[TBL] [Abstract][Full Text] [Related]
14. Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumors.
Desmoulin SK; Wang Y; Wu J; Stout M; Hou Z; Fulterer A; Chang MH; Romero MF; Cherian C; Gangjee A; Matherly LH
Mol Pharmacol; 2010 Oct; 78(4):577-87. PubMed ID: 20601456
[TBL] [Abstract][Full Text] [Related]
15. Structural and Enzymatic Analysis of Tumor-Targeted Antifolates That Inhibit Glycinamide Ribonucleotide Formyltransferase.
Deis SM; Doshi A; Hou Z; Matherly LH; Gangjee A; Dann CE
Biochemistry; 2016 Aug; 55(32):4574-82. PubMed ID: 27439469
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel pyrrolo[2,3-d]pyrimidine as tumor-targeting agents with selectivity for tumor uptake by high affinity folate receptors over the reduced folate carrier.
Golani LK; Islam F; O'Connor C; Dekhne AS; Hou Z; Matherly LH; Gangjee A
Bioorg Med Chem; 2020 Jun; 28(12):115544. PubMed ID: 32503687
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of 6-substituted pyrrolo[2,3-d]pyrimidines as dual inhibitors of TS and AICARFTase and as potential antitumor agents.
Liu Y; Li M; Zhang H; Yuan J; Zhang C; Zhang K; Guo H; Zhao L; Du Y; Wang L; Ren L
Eur J Med Chem; 2016 Jun; 115():245-56. PubMed ID: 27017552
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity profiles of novel 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolates with modified amino acids for cellular uptake by folate receptors α and β and the proton-coupled folate transporter.
Golani LK; George C; Zhao S; Raghavan S; Orr S; Wallace A; Wilson MR; Hou Z; Matherly LH; Gangjee A
J Med Chem; 2014 Oct; 57(19):8152-66. PubMed ID: 25234128
[TBL] [Abstract][Full Text] [Related]
19. Cellular Pharmacodynamics of a Novel Pyrrolo[3,2-
Dekhne AS; Ning C; Nayeen MJ; Shah K; Kalpage H; Frühauf J; Wallace-Povirk A; O'Connor C; Hou Z; Kim S; Hüttemann M; Gangjee A; Matherly LH
Mol Pharmacol; 2020 Jan; 97(1):9-22. PubMed ID: 31707355
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor activity of a novel series of 6-substituted pyrrolo[2,3-d]pyrimidine thienoyl antifolate inhibitors of purine biosynthesis with selectivity for high affinity folate receptors and the proton-coupled folate transporter over the reduced folate carrier for cellular entry.
Wang L; Cherian C; Desmoulin SK; Polin L; Deng Y; Wu J; Hou Z; White K; Kushner J; Matherly LH; Gangjee A
J Med Chem; 2010 Feb; 53(3):1306-18. PubMed ID: 20085328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
